Decoding the pancreatic cancer microenvironment: The multifaceted regulation of microRNAs
Open Access
- 27 June 2025
- journal article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 15 (7)
Abstract
Pancreatic cancer (PC) is an extremely deadly type of cancer, and the 5‐year survival rate remains less than 10%. The tumour microenvironment (TME) affects the occurrence, progression and treatment outcomes of PC. MicroRNAs (miRNAs) are essential to regulate PC TME. This review delves into the different roles of miRNAs in the PC TME, including exosome communication, angiogenesis, interactions with cancer‐associated fibroblasts, the immunological and neuronal microenvironments and metabolic reprogramming. However, research on the complex regulatory networks and synergistic effects of miRNAs in the TME is still insufficient, and their clinical translation and application face challenges. This review summarised the activities of miRNAs in the PC TME, guiding future research and therapeutic strategies involving miRNAs in PC. Future studies should integrate advanced technologies to decode the spatiotemporal dynamics of miRNA regulation within the TME and develop optimised nanodelivery systems for stable and targeted miRNA delivery, advancing clinical applications in PC treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82272624, 82471851)
This publication has 183 references indexed in Scilit:
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategiesAdvanced Drug Delivery Reviews, 2015
- Combined evaluation of a panel of protein and miRNA serum‐exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificityInternational Journal of Cancer, 2014
- Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203Cellular Immunology, 2014
- MicroRNA-mediated multi-tissue detargeting of oncolytic measles virusCancer Gene Therapy, 2014
- Stromal MicroRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancerJournal of Surgical Oncology, 2014
- Emerging roles of miR-210 and other non-coding RNAs in the hypoxic responseActa Biochimica et Biophysica Sinica, 2014
- DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic CancerPLOS ONE, 2013
- Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF TreatmentPLOS ONE, 2012
- Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes ApoptosisMolecular Cell, 2007
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971